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Background: This study was conducted to define the outcomes of treating aortic aneurysms involving the arch vessels with
a hybrid approach using extra-anatomic reconstruction and endovascular repair with nonfenestrated stents.
Methods: A single-center review was done of arch aneurysm endovascular repairs during an 8-year period. Data were
collected for patient demographics and aneurysm pathology. Any revascularization procedures performed were analyzed
to detect differences between groups and through fitting a logistic regression model. The outcome measures were
postoperative death, stroke, and paraplegia.
Results: Between 2001 and 2009, 78 patients (65% men; mean age, 65 years) underwent endovascular repair of aortic arch
aneurysms. Coverage of the left subclavian artery (LSA) was necessary in all patients to access an adequate proximal landing
zone. An Ishimaru zone 0 proximal landing zone was present in 9 patients, 17 had zone 1, and 52 had zone 2. Fifty patients
(64%) underwent elective endografting with an in-hospital mortality rate of 4%, and 28 patients (36%) underwent emergency
procedures with a mortality rate of 14.3%. The LSA was revascularized in 31 elective (62%) and 4 emergency patients (14%).
LSA revascularization was associated with significantly better outcomes for the combined measure of death, stroke, and
paraplegia (odds ratio [OR], 15.6; 95% confidence interval [CI], 1.83-142; P  .012). Patients with an atherosclerotic
aneurysm had worse outcomes than those with aortic dissection (OR, 5.52; 95% CI 1.26-24.4; P  .024), with dissections
having preponderance toward emergency procedures (OR, 2.92; 95% CI, 1.12-7.58; P  .035).
Conclusion: Aneurysms involving the aortic arch vessels can be effectively treated by staged endovascular-surgical hybrid
procedures with good outcomes that can be further improved through prior revascularization of the LSA. (J Vasc Surg
2010;51:1329-39.)Endovascular therapy is now one recognized treatment
for thoracic aortic pathology, including degenerative tho-
racic aneurysms, acute complicated and chronic dissections,
and aortic trauma. It has been suggested that morbidity and
death are both significantly reduced with endovascular
interventions compared with open surgery.1-3
Lesions that affect the aortic arch vessels are not only
the most technically challenging endovascular procedures
but also those for which the benefits of minimally invasive
surgery might be the most easily demonstrated. The chal-
lenges for this technique revolve around aortic arch mor-
phology. The 3-dimensional angulations of the aortic arch
and large hemodynamic forces, coupled with manipulating
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make accurate endograft placement a significant challenge.
The supra-aortic trunks add to the complexity of managing
these lesions endovascularly because they can impinge on
the potential proximal landing zone.
Balm, and later Ishimaru, devised an anatomic land-
ing zone map to assist in operative planning and report-
ing.4 Ishimaru zones 0 to 3 relate to the arch and zones
4 and above relate to the relatively straight segment of
the descending thoracic aorta. Aneurysms with proximal
deployment in zones 0 to 2 encompass the coverage of
one or more supra-aortic trunk ostia to create a satisfac-
tory proximal seal. Zone 0 lesions require coverage and
revascularization of the brachiocephalic trunk. Coverage
of the left common carotid artery origin and revascular-
ization by carotid-carotid (with or without subclavian)
bypass is mandated for pathology with a zone 1 landing
zone.
There remains disagreement regarding the operative
management of the left subclavian artery (LSA). Some have
reported satisfactory outcomes with intentional coverage of
the LSA.5,6 Others, however, advocate revascularization to
reduce the incidence of complications such as stroke, para-
plegia, and upper limb ischemia.7,8
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series to date of endovascular repair involving the arch
vessels that required coverage of the LSA to ensure com-
plete aneurysm exclusion and an adequate proximal landing
zone. Our goal was to clarify the role of LSA revasculariza-
tion in these patients and to further define the early post-
operative outcomes of arch aneurysm repair using hybrid
endovascular techniques.
METHODS
This series presents a review of a single-center experi-
ence of consecutive thoracic endovascular repair (TEVR)
procedures involving the arch vessels during the 8-year
period from 2001 to 2009. Patients were included in the
study if the thoracic endograft covered the origin of the
innominate artery, left common carotid artery, or LSA.
The proximal landing zone was defined with reference to
Ishimaru zones 0, 1, and 2.4 These criteria mean that a
number of zone 2 cases could be considered to be
descending thoracic aneurysms but with an insufficient
proximal landing zone to place an endograft without
over-stenting of the LSA.
Data were obtained from patient case notes and entered
into a dedicated database, including demographic, physio-
logic, pathologic, anatomic, and outcome data. Reported
outcomes focused on 30-day or in-hospital death, postop-
erative stroke, and postoperative paraplegia. A combined out-
come measure of death-stroke-paraplegia was also reported.
Primary technical success was assessed from intraoper-
ative imaging and postoperative computed tomography
(CT) scanning. Territorial information about any postop-
erative strokes was determined from CT or diffusion-
weighted magnetic resonance imaging. The motor func-
tional outcome of spinal cord ischemic injury was graded
according to Tarlov scale scores (Table I), and the time of
onset after surgery was noted.9 Immediate neurologic in-
jury was defined as a reduction from the preoperative
Tarlov score upon reversal of anesthesia. Any improvement
was noted, but the lowest score achieved was reported and
assessed by an independent neurologist.
Indications for thoracic endovascular repair. In the
St. George’s Vascular Institute, endovascular repair is the
first-line treatment modality for thoracic aneurysms, acute
aortic syndromes, and acute and chronic dissections. A
threshold of 5.5 cm was used for elective repair of non-
Table I. Tarlov scale score for motor functional
outcomes after spinal cord injury
Scale Motor function Deficit
0 No lower extremity movement Paraplegia
1 Lower extremity motion without gravity Paraplegia
2 Lower extremity motion against gravity Paraplegia
3 Able to stand with assistance Paraparesis
4 Able to walk with assistance Paraparesis
5 Normal Normalsymptomatic thoracic aneurysms and chronic dissections.Acute type B thoracic dissections were treated when com-
plicated by rupture, impending rupture (ie, rapid expan-
sion, intramural hematoma, left-sided pleural effusion), or
malperfusion, as described elsewhere.10,11
Thoracic debranching. Where feasible in elective
procedures, thoracic debranching procedures were staged
from the endovascular repair by a period of several weeks.
In emergency procedures, thoracic debranching was per-
formed simultaneously with insertion of the endograft. A
retrograde femoral approach was used for patients with
proximal attachment sites in Ishimaru zones 0 and 1.
Preoperative imaging detailed carotid and vertebral flow
and patency through duplex ultrasound studies and CT
scanning. Circle ofWillis patency and completeness was not
routinely assessed.
Zone 0 lesions were treated by debranching the innom-
inate and left common carotid arteries, followed by deploy-
ment of the thoracic endografts. This was achieved by
median sternotomy, application of a side-biting clamp to
the ascending aorta, and anastomosis of a 10-mm Dacron
graft (InterVascular, Datascope, La Ciotat, France) to the
innominate artery and an 8-mm graft to the left common
carotid artery. Two anastomoses were made with the as-
cending aorta, although other series report the successful
use of a bifurcated graft. Both distal anastomoses were
end-to-end to transacted arch vessels, with the proximal
origin being oversewn. The LSA, when treated, was revas-
cularized with a left carotid-subclavian bypass, which was
staged from the median sternotomy.
Zone 1 lesions underwent carotid-carotid crossover
bypass using an 8-mm Dacron conduit tunneled either
prepharyngeally or retropharyngeally. The decision about
which route to use was made on the likely clinical require-
ment for postoperative tracheostomy.
LSA revascularization, if performed, consisted of a syn-
chronous bypass from the crossover graft to the LSA. The
policy for LSA revascularization changed during the course
of this study for patients with proximal sealing in Ishimaru
zones 0, 1, and 2. During approximately the first half of the
study, prophylactic LSA revascularization was only used for
patients with absolute indications, such as left internal
mammary artery graft, hypoplastic or absent right vertebral
artery, or extensive coverage of the thoracoabdominal
aorta. In the last half of the series, the LSA was revascular-
ized in all elective cases and whenever possible in emer-
gency cases. Revascularization used a left carotid-subclavian
bypass with an 8-mm Dacron conduit. The change in policy
reflectedaccumulatingevidenceon the roleofLSArevasculariza-
tion in preventing neurologic sequelae during TEVR.8,12
Management of the spinal cord. Preoperative pro-
phylactic lumbar drains were used selectively in high-risk
patients, which included those with previous open or en-
dovascular abdominal aortic aneurysm repair, long stent
graft or distance of aorta covered (20 cm), and patients
who required prolonged ventilation that might prevent
recognition of deficit. The drain was set to a fixed pressure
of 10 cm H2O and allowed to drain cerebrospinal fluid
freely, up to 30 mL/h. Regardless of drain placement,
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 6 Holt et al 1331mean arterial pressure was maintained at 90 mm Hg
perioperatively with the use of inotropes, if required.
Endovascular procedure. Graft selection was made
on a case-by-case basis in a multidisciplinary setting. The
endografts used were the Valiant and Talent (Medtronic
Inc, Minneapolis, Minn), TAG (W. L. Gore & Associates,
Flagstaff, Ariz), and TX2 and Zenith (Cook, Bloomington,
Ind). The endovascular procedure was usually performed
with patients under general anesthesia. Manipulation of the
systolic pressure to 80 mm Hg was used for deployment
of the most proximal endograft. Rapid pacing or pharma-
cologically induced systole was not used in this series.
Statistical analysis. Analyses were performed using
SAS 9.0 software (SAS Institute Inc, Cary, NC). Differ-
ences between subgroups were quantified using Fisher’s
exact test. The relative effect of different factors on out-
come was quantified by fitting a logistic regression model,
and the covariates in the final model were identified using a
forward selection procedure. Odds ratios (OR) are pre-
sented with 95% confidence intervals (CI). Statistical sig-
nificance was set at P  .05.
RESULTS
Cohort demographics. Between May 2001 and April
2009, 78 patients (67% men) with a mean age of 65 years
(range, 33-86 years) underwent endovascular repair of
thoracic pathology involving the aortic arch vessels. Cover-
age of the LSA was necessary in all patients to access an
adequate proximal landing zone. The endovascular stent
grafting procedures were elective in 50 patients (64%; mean
age, 78.2 years) and emergencies in 28 (36%; mean age,
67.8 years; Table II). The procedures inmost of the elective
patients were staged, with 1 month to 6 weeks between
debranching and endografting. No ruptures occurred dur-
ing this interval, and all patients who underwent debranch-
ing were medically fit for endografting. No patients were
lost to follow-up in this period.
The median length of hospital stay for all procedures
combined was 10 days (range, 3-45 days) for elective cases
and 13 days (range 2-49) for emergency cases, with a
median critical care stay of 0 and 2.5 days, respectively.
The LSA was revascularized in 31 elective patients
(62%) and in 4 emergency patients (14%). Eight of nine
zone 0 patients had debranching procedures with a later
carotid-subclavian bypass. One emergency zone 0 patient
had a debranching of the innominate and left common
carotid artery only. Of the 17 zone 1 patients, 14 under-
went carotid-carotid-subclavian bypass, with the remaining
3 patients receiving a carotid-carotid bypass only. The
greatest variability was seen in the 52 zone 2 patients, in
whom only 13 had carotid-subclavian bypass.
Adverse outcomes. There were 14 adverse postoper-
ative outcomes in 12 patients, which were subdivided into
in-hospital death, stroke, and paraplegia. A combined out-
come measure of death-stroke-paraplegia was also reported
due to the overall low event rate and requirement of
multivariate analysis. Each patient was counted only once in
the combined outcome, therefore the total number ofcomplications exceeds the total number of combined out-
comes. Outcomes and the determinants of outcome were
investigated on a univariate and multifactorial basis.
The 14 events occurred in 12 patients who did not
undergo LSA revascularization (Table III), and all patients
except 1 had an Ishimaru zone 2 proximal landing zone.
Most of the complications occurred in the emergency
admission group (Table IV). For the purpose of all analyses,
the zone reported refers to the placement of the leading
edge of the fabric of the endovascular device.
Deaths. There were six in-hospital deaths (7.69%), all
occurring in patients who did not undergo LSA revascular-
ization. Five of the deaths were in zone 2 patients. A single
death occurred in a zone 0 patient who was an emergency
admission and did not undergo LSA revascularization. The
in-hospital mortality rate was 14.3% in the emergency group
and 4% in the elective cohort, which was not significantly
different. A protective effect of LSA revascularization for post-
operative death was demonstrated, with a mortality rate of
14% in patients without LSA revascularization vs 0% in those
with LSA revascularization (P .030).
Four of the six patients who died also had postoperative
renal failure, two after perioperative myocardial infarctions
with associatedmultiorgan failure, one after a postoperative
hemorrhage requiring repeat intervention, and one after
mesenteric ischemia and multiorgan failure. Two fatal
strokes occurred, one after a myocardial infarction with
multiorgan failure and the other in a patient with postop-
erative renal failure. Another death occurred in a patient
with acute dissection with malperfusion that was not attrib-
utable multiorgan failure, myocardial infarction, or cere-
brovascular accident. One death was attributable to aneu-
rysm rupture in a patient presenting as an emergency with
shock and radiologic evidence of arch aneurysm rupture in
whom endovascular management was attempted.
Two further deaths occurred during the first postoper-
ative year, giving a midterm mortality rate, including post-
operative deaths, of 10% at 1 year.
Stroke. All five strokes occurred exclusively in the pa-
tients without LSA revascularization (11.6% vs 0%; P .061).
The overall stroke rate was 6%, and all strokes were in zone 2
patients. Emergency operations were associated with a 14.3%
risk of postoperative stroke compared with 2% in elective
procedures (OR, 8.17; 95% CI, 1.14-56.7; P .053).
Two strokes were in the left middle cerebral artery
(MCA) territory, one was in the rightMCA territory, one was
a watershed distribution (left and right internal capsule), and
one was in the left cerebellum (posterior circulation). One of
the left MCA strokes was in an emergency patient who was
later found to have an 80% to 95% left internal carotid artery
stenosis (atherosclerotic). The carotid and vertebral circula-
tions in the rest of the patients were shown to be normal either
preoperatively or postoperatively, depending onwhether they
were elective or emergency admissions. Of note, the posterior
circulation stroke occurred in a patient whowas an emergency
admission with an atherosclerotic aneurysm with normal ver-
tebral and carotid arteries and antegrade flow in the vertebral
circulation.
atient
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developed in three patients (3.85%). All of these were in the
nonrevascularized group (6.98% vs 0%; .248). Two of these
patients had a zone 2 proximal landing zone and the other
a zone 1 but only underwent a carotid-carotid bypass. The
incidence of anterior cord symptoms was higher in the
emergency group (7.14% vs 2%; .291). All three patients
had atherosclerotic aneurysms (7.89% vs 0%; .111). The
single elective patient had normal carotid and vertebral
arteries preoperatively. With such low event rates, the uni-
variate analysis did not reach significance, although the
Table II. Summary data by Ishimaru zonea
Variable 0
Patients, No. 9
Age, mean (range), y 64 (41-74)
Gender, No.
Male 6
Female 3
Chronic renal disease, No. (%) 0 (0)
Preop creatinine, mean (SD), mol/L 82 (24)
eGFR,b mean (SD), mL/min/1.73 m2 94 (27)
Cardiac disease,c No. (%) 2 (22)
Previous cardiac valve surgery, No. (%) 5 (55)
CVD (previous TIA/CVA), No. (%) 1 (11)
Hypertension, No. (%)
Treated 7 (78)
Untreated 2 (22)
Diabetes
Type 1 0 (0)
Type 2 3 (33)
Smoking
Former smoker 5 (55)
Current 1 (12)
Never smoked 3 (33)
Hypercholesterolemia, No. (%) 4 (44)
Previous aortic surgery, % 56
ASA score, mean (range) 3 (2-4)
Emergency admissions, % 22
LSA revascularized, No. (%) 8 (89)
Max aortic diameter, mean (SD), mm 74 (23)
Length of aorta covered, mean (SD), mm 299 (50)
Dissection, No. (%) 6 (66.7)
Acute 0 (0)
Chronic 6 (100)
Aneurysm, No. (%) 3 (33.3)
Stroke, No. (%) 0
Paraplegia, No. (%) 0
Death, No. (%) 1 (11.1)
Combined outcome, No. (%) 1 (11.1)
Discharge destination,d No. (%)
Home 8 (100)
Referring hospital 0
Rehab facility 0
ASA, American Society of Anesthesiologists; CVA, cerebrovascular acciden
left subclavian artery; SD, standard deviation; TIA, transient ischemic attack
aThree patients with a proximal landing zone in zone 1 had carotid-carotid b
there were 14 events in 12 patients.
bCalculated by Modification of Diet in Renal Disease equation.
cIncludes previous myocardial infarction, coronary artery bypass grafting, o
dThe discharge destination (%) is calculated from the number of surviving ptrends observed might be informative.The elective patient made a partial recovery from a
Tarlov scale paraplegia score of 0 to 2. The onset of
paraplegia was 28 hours after surgery and was managed
with CSF drainage and blood pressure support. The two
emergency patients made no recovery (score 0) and were
paraplegic immediately after TEVR.
Phrenic nerve injury. No phrenic nerve injury oc-
curred in this series. This was avoided by the routine
identification and protection of the phrenic nerve during
dissection.
Dissection vs aneurysm. Forty patients (51.3%) un-
Ishimaru zone
Overall1 2
17 52 78
66 (44-85) 68 (33-86) 67 (33-86)
12 34 52
5 18 26
6 (35) 17 (33) 23 (29)
101 (32) 107 (62) 103 (54)
70 (22) 72 (46) 74 (40)
9 (53) 15 (29) 26 (33)
6 (11) 4 (8) 15 (19)
3 (6) 7 (13) 11 (14)
14 (82) 40 (77) 61 (78)
3 (18) 12 (23) 17 (22)
0 (0) 2 (4) 2 (2)
3 (17.6) 12 (23) 18 (23)
8 (47) 40 (77) 53 (68)
6 (35) 7 (13) 14 (18)
3 (18) 5 (10) 11 (14)
9 (53) 35 (67) 48 (62)
35 11.50 22
3 (3-5) 3 (3-5) 3 (2-5)
12 46 36
14 (82.4) 13 (25) 35 (44.9)
66 (17) 59 (18) 62 (19)
316 (101) 277 (88) 289 (89)
9 (52.9) 25 (48.1) 40 (51.3)
1 (11) 17 (68) 18 (45)
8 (89) 8 (32) 22 (55)
8 (47.0) 27 (50.9) 38 (48.7)
0 5 (9.43) 5 (6)
1 (5.88) 2 (3.85) 3 (3.85)
0 5 (9.62) 6 (7.7)
1 (5.88) 10 (19.2) 12 (15.4)
14 (82.3) 34 (72.3) 56 (77.8)
2 (11.8) 11 (23.4) 13 (18.1)
1 (5.9) 2 (4.26) 3 (4.17)
, cerebrovascular disease; eGFR, estimated glomerular filtration rate; LSA,
es only, and one zone 0 patient had a debranching procedure only. Overall,
taneous transluminal angioplasty with stent.
s only.t; CVD
.
ypass
r percuderwent endografting for acute complicated or chronic
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aortic syndromes, including acute complicated type B dis-
sections and 22 chronic type B. Compared with the 38
patients with atherosclerotic aneurysms, the dissection
cohort was younger, with a mean age of 61.5 years (range,
33-86 years) vs 72.3 (range, 53-85; P  .0001). The
patients with dissection were more likely to undergo an
emergency procedure (OR, 2.92; 95% CI, 1.12-7.59; P 
.035). Patients presenting with degenerative aneurysms
had a trend toward higher adverse outcome rates than those
with dissections despite being less likely to present as an
emergency (Table V).
Effect of LSA revascularization by regression
analysis. The logistic regressionmodel adjusted the results
for patient demographics (age, gender, emergency, or elec-
Table III. Outcomes data by left subclavian artery
revascularization
Outcome
Revascularized
Not
revascularized
P value(n  35) (n  43)
Stroke, No. (%) 0 5 (11.6) .061a
Paraplegia, No. (%) 0 3 (6.98) .248
Death, No. (%) 0 6 (14.0) .03
Combined outcome,b
No. (%) 0 12c (27.9) .0001
aStroke demonstrated a trend level significance.
bA patient could be counted only once in the combined outcome.
cRepresents 14 complications in 12 patients.
Table IV. Outcomes data by mode of admission
Outcome
Elective Emergency
P value(n  50) (n  28)
Stroke, No. (%) 1 (2) 4 (14.3) .053a
Paraplegia, No. (%) 1 (2) 2 (7.14) .291
Death, No. (%) 2 (4) 4 (14.3) .18
Combined outcome,b No. (%) 3 (6) 9 (32.1) .006
aStroke demonstrated a trend level significance.
bA patient could be counted only once in the combined outcome.
Table V. Outcomes data by pathology
Outcome
Aneurysm Dissection
P value(n  38) (n  40)
LSA revascularized,
No. (%) 19 (50) 16 (40) .495
Emergency presentation,
No. (%) 9 (23.7) 19 (47.5) .035
Age, mean (range), y 72.3 (53-85) 61.5 (33-86) .0001
Stroke, No. (%) 3 (7.89) 2 (0.5) .671
Paraplegia, No. (%) 3 (7.89) 0 (0) .111
Death, No. (%) 4 (10.5) 2 (0.5) .425
Combined outcomea 9 (23.7) 3 (7.5) .063
LSA, Left subclavian artery.
aThe combined outcome demonstrated a trend level significance.tive procedures) and aneurysm characteristics (Ishimaruzone, LSA revascularized, dissection or aneurysm, aneu-
rysm diameter, length of aorta covered). The full model was
significant (P  .0022), with final Akaike Information
Criterion of 57.6 andR2 of 0.600. Revascularization of the
LSA was associated with significantly better outcomes in
terms of death-stroke-paraplegia (OR, 15.6; 95% CI, 1.83-
142; P  .012). Patients with an atherosclerotic aneurysm
had a higher adverse outcome rate than patients with aortic
dissection (OR, 5.52; 95% CI, 1.26-24.4; P  .024).
Longer lengths of aorta covered were associated with
higher paraplegia rates, with an increase in odds of paraple-
gia of 1% per additional millimeter covered (OR, 1.012;
95% CI, 1.002-1.023; P  .028), which equated to a
doubling of the actual risk for each 100-mm length of
aortic coverage. No paraplegia occurred in patients with
aortic coverage of 250 mm.
On univariate analysis, atherosclerotic aneurysm diam-
eter was significantly associated with the combined out-
come, with a 5% increase in odds per millimeter of diameter
(P  .023) suggesting a doubling of risk for every 20-mm
increase in aneurysm diameter. No adverse outcomes were
reported in patients with aneurysms 60 mm in diameter.
This covariate just failed to reach significance in the multi-
factorial model (OR, 1.064; 95% CI, 0.999-1.134; P 
.055). Similarly, emergency admission was significant on
univariate analysis but not in the multifactorial regression
model. No other factors reached significance within the
model, including patient age and gender.
Endoleak, adjunctive procedures, and reinterven-
tions. The primary technical success in terms of aneurysm
exclusion was 97.4%, with a single type 1a and a single type
1b endoleak. The reinterventions are summarized (Table
VI). The type 1a endoleak was in an emergency patient with
a proven rupture of a thoracic aneurysm. The patient, who
was in extremis during the procedure, died soon after this
failed endograft deployment. The type 1b endoleak was
very small and considered of no clinical importance. It was
not treated and later resolved on follow-up imaging.
Two dissection flaps were ruptured intraoperatively.
Adjunctive procedures were required, consisting of renal
stents in one patient and a percutaneous dissection flap
fenestration in another. Both procedures were completed
successfully after these adjuncts. In another patient, the left
common carotid artery was partially covered and was suc-
cessfully treated with a self-expanding stent. One patient
required immediate open visceral revascularization after the
celiac axis and superior mesenteric artery were covered by
the endograft. No retrograde type A dissection was seen in
this series.
Type 2 endoleaks from the LSA were noted in 18
patients and were treated with Amplatzer occlusion plugs
(AGA Medical Corp, Plymouth, Minn) when the LSA had
been revascularized on the basis that these would be high
pressure. This might reasonably be considered a final stage
of the hybrid procedure because it is performed in such a
high percentage of cases. As such, the occluder placement is
not considered a reintervention. If the LSA was not revas-
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Pt Ishimaru zone Graft type Initial grafts, No. Length of aorta covered (mm)
1 0 Valiant 4 355
2 0 Valiant 1 210
3 0 Valiant 3 300
4 0 Valiant 4 341
5 0 ? ? 259
6 0 Valiant 3 352
7 0 Zenith 1 Missing
8 0 Valiant 3 263
9 0 Valiant (2 prox) and Talent (1 distal) 3 307
10 1 ? Missing
11 1 Valiant 2 294
12 1 Valiant 2 210
13 1 Valiant 2 261
14 1 Valiant 3 302
15 1 Valiant 2 341
16 1 Valiant 3 312
17 1 TX2 2 512
18 1 Talent 4 288
19 1 Valiant 2 421
20 1 Valiant 1 205
21 1 Valiant 2 568
22 1 Valiant 3 300
23 1 Valiant 4 274
24 1 Valiant 1 256
25 1 Valiant 2 270
26 1 Various 242
27 2 ? ? 335
28 2 Valiant 2 274
29 2 TAG 2 262
30 2 TAG 1 197
31 2 Valiant 1 215
32 2 Valiant 1 174
33 2 Valiant 2 293
34 2 Valiant 2 Missing
35 2 ? ? 187
36 2 Valiant 2 210
37 2 Valiant 1 202
38 2 TX2 and Cook Cage 2 286
39 2 Valiant 2 151
40 2 Valiant 4 530
41 2 TAG 2 262
42 2 TAG 2 257
43 2 Talent 2 155
44 2 Valiant 2 265
45 2 Valiant 1 208
46 2 Valiant 1 203
47 2 Valiant 3 344
48 2 Valiant 3 281
49 2 ? ? 258
50 2 Valiant 2 280
51 2 ? 1 132
52 2 Valiant 1 178
53 2 Talent 4 299
54 2 Valiant 3 376
55 2 Valiant 3 397
56 2 Valiant Left CCA access 4 Missing
57 2 Valiant 2 310
58 2 TX2 1 231
59 2 Valiant 2 275
60 2 Valiant 2 272
61 2 TX2 3 Missing
62 2 Valiant 1 201
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Endoleak detected Type of endoleak When managed Management of endoleak
Day 1 Type 2 Day 2 LSA plug
Day 1 Type 3 and type 2 3 mo Relined; 3 Valiant and LSA plug
Day 1 Type 2 Day 14 LSA plug
Intraop Type 2 Day 5 LSA plug
Day 7 Type 2 Day 9 LSA plug
Day 10 Type 2 4 and 6 mo LSA and aberrant RSA plugs
Intraop Rupture of dissection flap Intraop Renal stents
18 mo Type 3 18 mo Relined
Intraop Type 1A Intraop; unsuccessful TX2 device migrated distally during the course of the
procedure leaving an insoluble proximal type 1
endoleak
Intraop Type 2 Day 7 LSA plug
Intraop Type 2 Day 7 LSA plug
Intraop Type 2 Day 7 LSA plug
Day 3 Type 2 Day 4 LSA plug
Intraop Type 2 Day 7 LSA plug
Dissection; multiple reinterventions
Intraop Rupture of dissection flap Intraop Distal extension of graft. Flow into previous
aortobifemoral graft occluded due to compression
of true lumen; percutaneous fenestration made
Day 1 Type 2 Day 1 LSA plug
Day 1 Type 2 N/A Resolved
Day 1 N/A Day 2 Stent graft collapse; reballooned
2 y Type 3 2 y Relined
Intraop Left CCA ostium partial occlusion Intraop Self-expanding stent into CCA
5 Days Type 1A 18 mo Relined; 2 Valiant
1 y Type 1b 1 y Extended distally and relined; 2 Valiant
Intraop Coverage of SMA and coeliac Intraop Open visceral bypass
able; R
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Amplatzer plugs were not deployed.
Discharge destination. Of this cohort, 77.8% were
discharged home, 4.2% were discharged to rehabilitation,
and 18%were discharged to a referring hospital for ongoing
care or access to social services.
Midterm results. Reinterventions were required in 9
of the 68 patients (13%) with a minimum of 1-year follow-
up. Two type 1a endoleaks were detected at 15 and 18
months and one type 1b endoleak was detected at 12
months. These were treated by proximal or distal exten-
sions, respectively, or complete relining of the stent graft.
Five type 3 endoleaks were detected at between 2 and 12
months after the procedure, and the stent grafts were
relined. The etiologies were a single fabric tear and four
graft component dislocations. A single pseudocoarctation
on day 2 caused by a partially collapsed graft was treated by
repeat balloon expansion of the stent graft.
DISCUSSION
This study represents the largest reported series to date in
the world literature regarding the endovascular treatment of
arch aneurysms. The data demonstrate that endovascular-
surgical hybrid procedures can be used to treat these aneu-
rysms at an acceptablemorbidity andmortality rate and that
revascularization of the LSA reduced the overall risk of arch
aneurysm endografting in terms of death, stroke, and para-
plegia. Patients presenting as an emergency and with aneu-
rysms, in contrast to dissections, had worse outcomes in
this series.
Significant advances in stent graft technology in recent
years have broadened the indications for endovascular tho-
racic intervention, making management of the aortic arch a
feasible treatment option in specialist units. Increasingly,
this includes lesions of the ascending aorta as well as distal
arch lesions. To effectively manage these complex lesions, a
variety of techniques have been developed to allow expan-
Table VI. Continued.
Pt Ishimaru zone Graft type
63 2 Valiant
64 2 Valiant
65 2 Valiant
66 2 ?
67 2 Valiant
68 2 Valiant
69 2 Valiant
70 2 Valiant
71 2 Valiant
72 2 Valiant
73 2 Valiant
74 2 Valiant
75 2 Valiant
76 2 Cook Proform
77 2 Valiant
78 2 Valiant
CCA, Common carotid artery; LSA, left subclavian artery; N/A, not applicsion of the proximal landing zone, which allows endograftplacement and promotes an effective proximal seal. These
extra-anatomic bypass procedures have been performed
readily in elective and emergency settings as a staged or as a
combined hybrid procedure.13,14
Early reports on the use of stent grafts in the aortic arch
suggested that the LSA need not be revascularized in most
patients and that this might avoid the operative morbidity
of a hybrid procedure.5,6,15-19 More recent data, however,
have been contradictory, with most studies supporting LSA
revascularization.7,8,20,21
The experience of this vascular institute supports a
reduction in morbidity and death with LSA revasculariza-
tion. From this series, only two complications occurred as a
result of the revascularization procedure itself, comprising
one chronic sinus to an infected graft and one postoperative
hematoma requiring reintervention. These surgical proce-
dures can therefore be delivered with a very low morbidity
rate. Notably, all patients underwent endografting with no
interval ruptures or failures to complete treatment due to
unfit patients. This is in contrast to reports of endovascular-
surgical hybrid procedures with visceral revascularization
for thoracoabdominal aneurysms.
Aside from the general technical issues of the bypass or
transposition, the choice of tunnel used in carotid-carotid
bypass (retropharyngeal or subcutaneous) should be con-
sidered preoperatively. This might be especially important
in patients with significant respiratory comorbidity who
might ultimately require a tracheostomy.
Previous studies have suggested that endografting of
the aortic arch carries significant risks of death, stroke, and
paraplegia, with worse results for more proximal proce-
dures.22,23 Although there is no longer clinical uncertainty
that endografting carries a lower operative mortality rate
than open surgical repair for aneurysms and dissection, the
risks are still significant.1,2,24 If there are ways that this risk
can be reduced, these should be defined and made routine
practice. This study, with demonstrable reductions in ad-
Initial grafts, No. Length of aorta covered (mm)
3 471
2 240
3 315
2 Missing
3 421
2 360
1 Missing
2 364
1 314
2 371
3 318
2 235
2 296
1 129
3 423
2 240
SA, right subclavian artery; SMA, superior mesenteric artery.verse outcomes, would suggest that LSA revascularization
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found that endografting the proximal arch was achievable
with a low risk, in contrast to the findings ofMelissano et al.21
Previous studies have defined absolute indications for
LSA revascularization, which were long thoracic aortic
segment coverage (20 cm), prior abdominal aortic aneu-
rysm repair, upper limb ischemic symptoms after en-
dografting,25 coronary artery graft bypass with the left
internal mammary artery, and current hemodialysis access
in the left arm.22,26,27 The study results would support the
first of these from the logistic regression model, and we
would support each of the other indications, although
these were not clearly demonstrated by our data.
The stroke rate in this cohort was 6%, and most of these
occurred in emergency patients. Previous studies have re-
ported a variable effect for LSA revascularization and
stroke, with the European Collaborators on Stent-Graft
Techniques for Aortic Aneurysm Repair (EUROSTAR)
experience suggesting that revascularization was not pro-
tective.5,6,8,27 However, those authors routinely docu-
mented vertebral artery dominance and patency preopera-
tively.5,6 Conversely, not revascularizing the LSA was seen
as a risk factor for stroke in a number of other studies and
these data would support this.12,18,28,29 The strokes that
we observed occurred in both posterior and carotid circu-
lation territories, suggesting a multifactorial etiology. In
particular, emboli from arch instrumentation and wire ma-
nipulation must be considered in addition to the hemody-
namic risks of over-stenting the LSA, and this embolic risk
must be assessed preoperatively. The hemodynamic effects
and a steal effect might be minimized by prior LSA revas-
cularization.
The reported paraplegia rates of 1% to 6% after thoracic
endovascular procedures are significantly lower than those
from open surgery, which can be as high as 21%,1,26,30,31
although lower rates have been reported.32 These data
suggested that reductions in spinal cord ischemia might be
Table VI. Continued.
Endoleak detected Type of endoleak Whe
Day 1 Type 2 Day 9
2 mo Type 3 2 mo
1 y Type 3 1 y
Intraop Type 1b Not tre
15 mo Type 1a 15 mo
Day 2 Type 2 Not tre
Day 2 Type 2 2 moattainable through LSA revascularization, with spinal cordischemia rates observed in this study of 0% in the revascu-
larized group and nearly 7% in the nonrevascularized
group. The incidence of spinal cord ischemia was higher in
emergency presentations and in patients in whom longer
lengths of the thoracic aorta were covered. These findings
are consistent with the published evidence and risk factors
for the development of paraplegia.22
Although the proposed mechanisms underlying spinal
cord ischemia in endografting differ from those in open
repair, the risks remain significant and units must have
robust policies in place for lumbar CSF drainage and post-
operative blood pressure manipulation. The number of
adverse events in this study was too small to assess an
association between spinal drainage and the incidence of
spinal cord injury.
CONCLUSIONS
The future of treatment of aortic arch aneurysms has
been usefully debated by a number of authorities. It re-
mains unclear whether the direction lies with a totally
endovascular solution through fenestrated or branched
grafts or through endovascular-surgical hybrid procedures.
Certainly, current solutions involving in situ fenestrations
and chimney grafts represent a compromise inmanagement
at best and must be currently considered purely experimen-
tal. The results of this study suggest convincingly that arch
aneurysm repair can be done at a low mortality rate and
acceptable morbidity using a staged hybrid repair with
minimal morbidity from the surgical stage. As well as
assiduous endovascular planning for stenting the aortic
arch, we suggest that LSA revascularization is mandated in
these procedures whether elective or emergency.
Our study represents the largest single-center series to
date on the outcome of endovascular stent grafting of
aortic arch aneurysms that required coverage of the LSA.
These results from the St. George’s Vascular Institute show
that LSA coverage without revascularization is associated a
naged Management of endoleak
LSA plug
Relined; 2 Valiant
Relined; 1 Valiant
Prox extension; 1 Valiant
LSA plugn ma
ated
atedhigher combined rate of death, stroke, and paraplegia.
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dergo LSA revascularization using a staged procedure.
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